Explore more Johnson & Johnson sites:
Share
Advancing Equitable Access to Care for Everyone, Everywhere
Back to top
Advancing Equitable Access to Care for Everyone, Everywhere
Advancing Access and Innovation for Health Equity
Advancing Access and Innovation for Health Equity
or more than a decade, Johnson & Johnson has been recognized by the independent Access to Medicine Foundation as one of the top three companies working to advance access to medicines and technologies in low- and middle-income countries.
This consistent recognition of our leadership is the result of a longstanding, deliberate and focused strategy aimed at solving some of the most difficult global health challenges and advancing equitable access to care for everyone, everywhere.
Learn more about how we never stop working to ensure good health for the people we serve.
More Than a Decade of Leadership in Access to Innovation
Our relentless focus on equitable access to healthcare is reflected in its consistent high ranking on the Access to Medicine Index (ATMI), a biennial report card that grades the world’s largest pharmaceutical companies on their efforts to distribute medications, vaccines and diagnostics to low- and middle-income countries. For ten years, Johnson & Johnson has placed in the top three on the list and in the 2021 report, we have once again earned a #3 spot overall, and advanced two places in the research and development category to take the #2 spot. Our consistent performance in the top three position underscores the our deep history of ensuring people in underserved communities receive the treatments they need.
Our Commitment to Advance Access to Medicines and Technologies
-
The Access to Medicine Index, a ranking of pharmaceutical companies' work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company's deep history of ensuring people in underserved communities receive the treatments they need.
-
Everyone deserves to live a healthy life. Yet all too often disease or inequities in access to care compromise a person’s health.
Spotlight on Our Breakthrough Access Programs
Champions for Access
We are committed, more than ever before, to advance a safer, healthier and more equitable world where everyone can thrive.
Our Global Public Health unit works to expand equitable access to our medicines and technologies for the world's most underserved people.
Our research and development pipeline focuses heavily on diseases that primarily impact underserved populations—and we integrate access planning into everything we do.
Our 25 years of experience in addressing global health challenges is informing our response to COVID-19, a global crisis that is laying bare the global inequities in accessing care.
We're committed to expanding equitable access to care in Africa by strengthening health systems, supporting frontline health workers and investing in local partnerships.